Melissa Geller
Professor, Division of Gynecologic Oncology · University of Minnesota
Credentials: · · · · ·
History
- Present
- 2005–2008
Gynecologic Oncology
- 2001–2005
Obstetrics and Gynecology
Research
Gene expression markers of Tumor Infiltrating Leukocytes
Journal for ImmunoTherapy of Cancer · 2017 · 635 citations
The Lancet Oncology · 2019 · 431 citations
Cytotherapy · 2011 · First of 14 authors · 360 citations
34 papers · 2 as a fellow
21 papers
- LD
20 papers · 1 as a fellow
16 papers · 3 as a fellow
- DT
15 papers
- LC
15 papers
- PJ
14 papers
10 papers · 5 as a resident
Grants
- 1998–2029
National Cancer Institute · P30
Project lead · $1.9M · University of Minnesota
- 2005–2027
NK Cells, Their Receptors and Cancer Therapy
National Cancer Institute · P01
Project lead · $1.8M · University of Minnesota
- 2008–2009
GCRC-General Clinical Research Center
National Center for Research Resources · M01
Project lead · $8.1K · University of Minnesota
Clinical trials
- 2023–2027
Study of PAT in Patients With Solid Tumor Cancers
Principal investigator · Recruiting · Phase 1
Masonic Cancer Center, University of Minnesota
- 2022–2025
HCW9218 in Select Advanced Solid Tumors
Principal investigator · Completed · Phase 1
Masonic Cancer Center, University of Minnesota
- 2021–2022
FT516 and IL2 With Enoblituzumab for Ovarian Cancer
Principal investigator · Completed · Phase 1
Masonic Cancer Center, University of Minnesota
- 2017–2021
Intraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) With Intraperitoneal Int
Principal investigator · Completed · Phase 1
Masonic Cancer Center, University of Minnesota